InsidersTradesSigma
Follow the Biocon Limited stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Biocon Limited has recorded 275 reports. Market capitalisation: €692.6bn. The latest transaction was reported on 4 April 2024 (Pledge). Among the most active insiders: MANEESH H GHILDYAL. The full history is accessible without an account.
275
Insider Decl.
n/a
Thresholds
€28m
136 ops.
Buy Volume
€10m
127 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Biocon Limited Buy (bullish), based on 20 analysts. Average price target: ₹423.70.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,970 of 28,985 companies
36.7
score / 100
Value30
Quality43
FCF yld0.1%
Earn yld0.6%
EV/EBITDA25.1x
ROE1.1%
Gross mgn66%
Net mgn2.3%
Debt/EBITDA4.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 April 2024
Declarations275 total
61,827 shares@ ₹256.6016.1% of flowEquity SharesSEBI:d33423a0ae50c4940d55377ef2ebf5b3f1994265
7,328 shares@ ₹256.6020.6% of flowEquity SharesSEBI:c78f095209f404792fd65f44b2c74f009929367e
19,998 shares@ ₹264.3449.4% of flowEquity SharesSEBI:c5839accdeefcf11dbce01d25734d202a6bb77f5
11,000 shares@ ₹260.5511.9% of flowEquity SharesSEBI:ed16c3fd0c3b26e381e0866cdacdf32892ac94ed
6,792 shares@ ₹251.65100.0% of flowEquity SharesSEBI:8c02a46ef9e9423c1c87d009b7223b85c370dd1c
1,000 shares@ ₹275.800.7% of flowEquity SharesSEBI:c8faefb6f687fedbbd2bd70e9c52d31f245f90fa
2,000 shares@ ₹270.951.3% of flowEquity SharesSEBI:ed4c1879ec720ca56279261cbcb527ab0623aa97
5,000 shares@ ₹283.003.4% of flowEquity SharesSEBI:7232bad934bf214da087dd015e0eabf8cfedd242
1,000 shares@ ₹277.350.7% of flowEquity SharesSEBI:0f67abf84d1abf1a8100e4c3baa4aec831e28dfe
1,000 shares@ ₹278.550.7% of flowEquity SharesSEBI:8c72120d5d04071253ec5e5e6b5eb2eb855cde30
20,500 shares@ ₹274.55100.0% of flowEquity SharesSEBI:1dc30af5c2b2bda027dd78ecc0f7201ae33dcf8c
2,000 shares@ ₹279.201.3% of flowEquity SharesSEBI:fa3811b1d532f786d15662e39554072f8dbca8cc
1,000 shares@ ₹277.500.7% of flowEquity SharesSEBI:6425d6aa8d074f3e64f9598813600bf3d19563b5
5,000 shares@ ₹272.503.2% of flowEquity SharesSEBI:68ae0f0041478b87778fbe50351ed7a2f775661c
2,000 shares@ ₹270.451.3% of flowEquity SharesSEBI:19d39aa5e7b35b616b3e7dca35b0178811a620e8
3,000 shares@ ₹269.182.0% of flowEquity SharesSEBI:408a5483dc17e22ad22a6f5203faa4780d60d492
1,000 shares@ ₹271.050.7% of flowEquity SharesSEBI:07a977f84876cf829f0ee8fed71af8bcf4a5651c
5,944 shares@ ₹249.599951.3% of flowEquity SharesSEBI:445c651aaa33be3b246ec5f3ae1539cf00efd8d9
4,980 shares@ ₹248.525123.9% of flowEquity SharesSEBI:50c8c5bdda04c372615367c7790c7336db7f49e2
8,007 shares@ ₹248.525100.0% of flowEquity SharesSEBI:b5b7c42d85acb43edb8dcb2f9bc0cb6a4d5a5eba
36,000 shares@ ₹248.52524.5% of flowEquity SharesSEBI:fb9f062186e70566c08ac2b200d406d5d13f026f
2,000 shares@ ₹246.251.2% of flowEquity SharesSEBI:ab85a60903abea137b410ce909048f44ab90ed1c
2,000 shares@ ₹249.681.2% of flowEquity SharesSEBI:2e5c1d16262dd65df0a62a4a844a818c68cc94c9
3,000 shares@ ₹254.751.8% of flowEquity SharesSEBI:ce9fce6fdcfa0c1b3007731ef1b22b0a907ba0dd
5,001 shares@ ₹246.3749100.0% of flowEquity SharesSEBI:899d5dbf88c4de7057755889e35164ec96eb7970
25 of 275 declarations
About Biocon Limited
Biocon Limited is an Indian biopharmaceutical company focused on the research, development, and manufacturing of drugs. It specializes in oncology, diabetes, and autoimmune diseases.